A wrongful death lawsuit against the valsartan pills manufacturer has been filed on May 1 in the U.S. District Court of N.J. by the family of a man who resided in Kentucky and passed away in 2018. They claim that it caused liver cancer as a result of chemical impurities and that same drug was recalled a few weeks after his passing.
Valsartan treats high blood pressure as the diseased parted taking those pills in 2014 – 2018. Nevertheless in the fall of 2017 Shepherd was diagnosed with liver cancer which is one of the diseases ‘connected to‘ as the side effects of valsartan pills which contains N-nitrosodimethylamine (NDMA) or N-Nitrosodiethylamine (NDEA): chemical impurities known to be a byproduct of the manufacturing process.
We have seen some valsartan recalls as of 2018 due to the presence of NDMA and NDEA.
There are class action lawsuits in regards to valsartan alleging damages for those who used the medications yet they have not been diagnosed with cancer, many plaintiffs are seeking reimbursement for the cost of terribly manufactured drugs, and they are looking for funding for medical monitoring that might be needed for the rest of their lives.
For victims who have been diagnosed with cancer or those who lost loved ones to liver cancer after using valsartan, there are specifically valsartan lawsuits handled by top product liability law firms.
